These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34070233)

  • 1. Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines.
    Prajapati S; Hinchliffe T; Roy V; Shah N; Jones CN; Obaid G
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.
    Bhandari C; Guirguis M; Savan NA; Shrivastava N; Oliveira S; Hasan T; Obaid G
    Nano Today; 2021 Feb; 36():. PubMed ID: 33552231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep-Tissue Activation of Photonanomedicines: An Update and Clinical Perspectives.
    Shah N; Squire J; Guirguis M; Saha D; Hoyt K; Wang KK; Agarwal V; Obaid G
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nanomedicines for synergistic photodynamic immunotherapy based on tumor immune microenvironment.
    Guo R; Liu Y; Xu N; Ling G; Zhang P
    Eur J Pharm Biopharm; 2022 Apr; 173():103-120. PubMed ID: 35283303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy.
    Xu X; Li T; Jin K
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Cell Membrane-Coated Nanoparticles for Cancer Management.
    Harris JC; Scully MA; Day ES
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnological selection.
    Demming A
    Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
    Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane composition is a functional determinant of NIR-activable liposomes in orthotopic head and neck cancer.
    Guirguis M; Bhandari C; Li J; Eroy M; Prajapati S; Margolis R; Shrivastava N; Hoyt K; Hasan T; Obaid G
    Nanophotonics; 2021 Sep; 10(12):3169-3185. PubMed ID: 35433177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting.
    Wang R; Sha X
    Curr Drug Targets; 2021; 22(8):882-895. PubMed ID: 33459231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy.
    Liu J; Yan J; Yan S; Wang Y; Zhang R; Hou P; He W; Ji M
    Nano Lett; 2019 Dec; 19(12):8708-8715. PubMed ID: 31744296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
    Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
    ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Targeted Nanomedicine for Immunotherapy.
    Cabral H; Kinoh H; Kataoka K
    Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-Infrared Light-Triggered Polymeric Nanomicelles for Cancer Therapy and Imaging.
    Li L; Pang X; Liu G
    ACS Biomater Sci Eng; 2018 Jun; 4(6):1928-1941. PubMed ID: 33445263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of NIR Fluorescence in MDR Cancer Treatment: From Targeted Imaging to Phototherapy.
    Wang Z; Meng Q; Li S
    Curr Med Chem; 2020; 27(33):5510-5529. PubMed ID: 31244415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.